Skip to main content Skip to section navigation Skip to footer
ASP Isotopes Inc.
  • Home
  • About Us
    • Our Company
    • People
  • Technology
  • Products
    • Medical
    • Semiconductors
    • Quantum Leap Energy
  • Investor
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Info
    • SEC Filings
    • Governance
  • Contact
    • Send a message
    • Sign up for news
Menu
  • Home
  • About Us
    • Our Company
    • People
  • Technology
  • Products
    • Medical
    • Semiconductors
    • Quantum Leap Energy
  • Investor
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Info
    • SEC Filings
    • Governance
  • Contact
    • Send a message
    • Sign up for news

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Fact Sheet
    • Executive Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
July 28, 2025 • 8:31 AM EDT

ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment

July 25, 2025 • 8:59 AM EDT

Competition Commission of South Africa Approves the Offer by ASP Isotopes Inc. for Renergen Limited

July 23, 2025 • 6:15 PM EDT

ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock

July 17, 2025 • 8:00 AM EDT

ASP Isotopes Inc. Announces Updates on the Progress of Commercial Production at its Three Enrichment Facilities in South Africa

July 11, 2025 • 8:00 AM EDT

Shareholders of Renergen Limited Approve Proposed Acquisition by ASP Isotopes Inc.

June 11, 2025 • 8:23 AM EDT

ASP Isotopes Inc. Enhances the Quantum Leap Energy LLC (QLE) Executive Leadership Team with the Appointment of Ryno Pretorius as Chief Executive Officer of QLE

June 4, 2025 • 9:00 AM EDT

ASP Isotopes Inc. to host Investor Access Event in South Africa from June 16-18, 2025

June 4, 2025 • 8:30 AM EDT

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

June 2, 2025 • 9:15 AM EDT

ASP Isotopes Inc. Announces Pricing of $50 Million Underwritten Registered Direct Offering of Common Stock

May 29, 2025 • 8:11 AM EDT

ASP Isotopes Issues Letter to Shareholders

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
About us

Our Company

People

Products

Medical

Semiconductors

Green Energy

Investors

Overview

News & Events

Company Info

Financial Info

Stock Info

SEC Filings

Governance

Other links

Home

Technology

Contact

Copyright © ASP Isotopes 2025. All Rights Reserved.

Terms & Conditions | Privacy Policy | Cookie Notice

X-twitter Linkedin